Join
Live feed
·
INSIDERFilingvia Quantisnow
Processa Pharmaceuticals Inc. logo

Chief Development Officer Bigora Sian converted options into 15,059 shares and covered exercise/tax liability with 3,311 shares, increasing direct ownership by 54% to 33,626 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCSA (Processa Pharmaceuticals Inc.) and more on Quantisnow.